Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models

doi:10.3748/wjg.v24.i12.1321

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9597)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-9) series.

Item

Count

PDF

561

WORD

205

HTML

4021

Figures (1-3)

303

Tables (1-9)

257

Sum=5347

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

842

Download

729

Sum=1571

Publishing Process of This Article

Item

Count

Browse

1140

Download

1539

Sum=2679

Mar 28, 2018 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Mar 28, 2018; 24(12): 1321-1331
Published online Mar 28, 2018. doi: 10.3748/wjg.v24.i12.1321

Table 3 GALAD-z and GALAD score calculation

GALAD-z = -10.08 + 0.09 × (Age) + 1.67 × (sex) + 2.34 × log(AFP) + 0.04 × (AFP-L3) + 1.33 × log(DCP)

GALAD score = exp (GALAD-z)/[1 + exp(GALAD-z)]

Sex = 1 for male and 0 for female.

Citation: Wongjarupong N, Negron-Ocasio GM, Chaiteerakij R, Addissie BD, Mohamed EA, Mara KC, Harmsen WS, Theobald JP, Peters BE, Balsanek JG, Ward MM, Giama NH, Venkatesh SK, Harnois DM, Charlton MR, Yamada H, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR. Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models. World J Gastroenterol 2018; 24(12): 1321-1331
URL: https://www.wjgnet.com/1007-9327/full/v24/i12/1321.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i12.1321